SOX2 recruits KLF4 to regulate nasopharyngeal carcinoma proliferation via PI3K/AKT signaling

被引:0
|
作者
Jianming Tang
Guansheng Zhong
Jianhui Wu
Haiyan Chen
Yongshi Jia
机构
[1] People’s Hospital of Hangzhou Medical College,Department of Radiation Oncology, Zhejiang Provincial People’s Hospital
[2] People’s Hospital of Hangzhou Medical College,Department of Thyroid and Breast Surgery, Zhejiang Provincial People’s Hospital
[3] Meizhou People’s Hospital,Department of The Otolaryngology
[4] The Second Affiliated Hospital of Zhejiang University School of Medicine,Department of Radiation Oncology
来源
Oncogenesis | / 7卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
SOX2 is a transcription factor that contributes to transcription modification and cancer, but the mechanism by which SOX2 regulates nasopharyngeal carcinoma cell proliferation is not well understood. Here, we identify a SOX2 signaling pathway that facilitates nasopharyngeal carcinoma, where it is upregulated. SOX2 expression was associated with nasopharyngeal carcinoma patient survival. SOX2 knockdown inhibited cell proliferation, colony formation, and tumorigenesis in an subcutaneous mouse xenograft model system. Six hundred and ninety-nine candidate SOX2 downstream dysregulated genes were identified in nasopharyngeal carcinoma cells through cDNA microarray analysis. SOX2 recruited the nuclear transcription factor KLF4 to bind to the PIK3CA promoter upregulate PIK3CA expression, acting to enhance PI3K/AKT signaling and tumorigenesis by upregulating PIK3CA expression. Besides, overexpressing activated AKT or PIK3CA rescued the growth inhibition of cells due to SOX2 knockdown. Together, our study suggest that SOX2 exhibits oncogenic properties and may be a reliable molecular biomarker in nasopharyngeal carcinoma. Targeting SOX2 might be a promising treatment strategy for nasopharyngeal carcinoma treatment.
引用
收藏
相关论文
共 50 条
  • [21] Fangchinoline suppresses nasopharyngeal carcinoma progression by inhibiting SQLE to regulate the PI3K/AKT pathway dysregulation
    Xie, Jieyun
    Shi, Zexian
    Sun, Lingling
    Wu, Yihong
    Feng, Jiuhuan
    Wang, Han
    Lai, Haifeng
    PHYTOMEDICINE, 2025, 140
  • [22] Carboxylesterase 4A Inhibits the Malignant Biological Behavior of Nasopharyngeal Carcinoma via the PI3K/AKT Pathway
    Chen, Qiaoli
    Hao, Quanxiang
    Yang, Yanping
    Li, Limei
    Li, Danping
    Zhao, Ran
    Wei, Wanqi
    Deng, Lixian
    Su, Jiaming
    Liang, Ziyuan
    Tang, Shiyue
    Lu, Yaomin
    Liang, Yushan
    Zhang, Zhe
    Zhou, Xiaoying
    Xiao, Xue
    Li, Ping
    Huang, Yi
    Zhao, Weilin
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2025, 24
  • [23] Euscaphic acid inhibits proliferation and promotes apoptosis of nasopharyngeal carcinoma cells by silencing the PI3K/AKT/mTOR signaling pathway
    Dai, Weibo
    Dong, Pengpeng
    Liu, Jing
    Gao, Yuqiao
    Hu, Ying
    Lin, Hui
    Song, Ye
    Mei, Quanxi
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2019, 11 (04): : 2090 - 2098
  • [24] Isorhamnetin inhibits cholangiocarcinoma proliferation and metastasis via PI3K/AKT signaling pathway
    Tan, Zhiguo
    Liu, Jie
    Hou, Min
    Zhou, Jia
    Chen, Yu
    Chen, Xu
    Leng, Yufang
    DISCOVER ONCOLOGY, 2025, 16 (01)
  • [25] KLF4 regulates FAM3A to promotes angiotensin II-induced proliferation and migration of vascular smooth muscle cells through the PI3K/AKT signaling pathway
    Zhang, Min
    Lei, Rong
    Wang, Liqiong
    Jiang, Yimin
    Zhou, Xiaoyan
    Wang, Yuquan
    PEPTIDES, 2025, 187
  • [26] Targeting PI3K signaling in a xenograft model of nasopharyngeal carcinoma
    Merritt, David M.
    Smith, Pamela
    Thorley-Lawson, David A.
    CANCER RESEARCH, 2010, 70
  • [27] Amplification of SOX4 promotes PI3K/Akt signaling in human breast cancer
    Mehta, Gaurav A.
    Parker, Joel S.
    Silva, Grace O.
    Hoadley, Katherine A.
    Perou, Charles M.
    Gatza, Michael L.
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 162 (03) : 439 - 450
  • [28] Amplification of SOX4 promotes PI3K/Akt signaling in human breast cancer
    Gaurav A. Mehta
    Joel S. Parker
    Grace O. Silva
    Katherine A. Hoadley
    Charles M. Perou
    Michael L. Gatza
    Breast Cancer Research and Treatment, 2017, 162 : 439 - 450
  • [29] Amplification of SOX4 promotes PI3K/Akt signaling in human breast cancer
    Mehta, Gaurav
    Gatza, Michael
    Angus, Steve
    Johnson, Gary
    CANCER RESEARCH, 2018, 78 (13)
  • [30] Sox2 is involved in paclitaxel resistance of the prostate cancer cell line PC-3 via the PI3K/Akt pathway
    Li, Dong
    Zhao, Li-Nan
    Zheng, Xiu-Lan
    Lin, Ping
    Lin, Feng
    Li, Yue
    Zou, Hai-Feng
    Cui, Rong-Jun
    Chen, Hui
    Yu, Xiao-Guang
    MOLECULAR MEDICINE REPORTS, 2014, 10 (06) : 3169 - 3176